Managing Anxiety and Depression in Parkinson’s Disease

A combination of medication and other therapies can help ease non-motor symptoms affecting those with Parkinson’s disease.

1:00 PM

Author | Andrew J. Ridder, M.D.

Silhouette showing anxiety & depression in Parkinson’s disease

Most people think of Parkinson's disease as marked only by tremors, muscular rigidity and slow, imprecise movements, but Parkinson's is more than a movement disorder.

Most people with Parkinson's also have quite a few non-motor symptoms, such as anxiety, depression and psychosis. Many of these symptoms may have started before the Parkinson's disease became obvious.

The effects are widespread. Several years ago, a large clinical study of more than 1,000 people with Parkinson's disease of various durations demonstrated that only 1.4 percent of the participants did not report any non-motor symptoms.

In other words, 98.6 percent of the study participants had some form of NMS. Psychiatric symptoms accounted for 60 percent, while visual hallucinations that could have signified psychosis were present in about 35 percent of patients.

That's why taking action is important. If you or a loved one has had a new diagnosis of Parkinson's disease, we recommend an immediate evaluation for depression, mood and cognitive problems. Frequent monitoring should also be done throughout the course of the disease.

Here are some of the common symptoms and treatment methods for Parkinson's patients with depression and dementia:

Identifying and treating depression

Between 17 to 50 percent of patients with Parkinson's have depression. Depression and Parkinson's have so many similar-looking symptoms that it is hard to tell the difference between them.

It's important to note, however, that depression is not a reaction to the disability. Rather, it seems to be related to the degeneration of specific neurons in Parkinson's disease itself.

Typical symptoms include:

  • Sadness

  • Pessimism

  • Decreased interest in activities

  • Slowing of movements

  • Fatigue

  • Mild to moderate depression

Major depression is accompanied with guilt and self-blame, which you don't often see in Parkinson's disease depression.

To treat depression in these cases, we would use the same treatments used to treat depression in the general population.

  • Selective serotonin reuptake inhibitors (SSRIs) such as paroxetine or sertraline

  • Serotonin/norepinephrine reuptake inhibitors (SNRIs) such as venlafaxine

  • Tricyclic antidepressants or MAO-B inhibitors are rarely used

  • Cognitive behavioral therapy: A type of psychotherapy in which the patient is given the tools to change negative patterns of thought about how they're reacting to things, coping with family members and their abilities. It is often combined with medications.

  • Vagus nerve stimulation, also known as vagal nerve stimulation: A medical treatment that involves delivering electrical impulses to the vagus nerve. It is used as an additional therapy for treatment-resistant depression and certain types of uncontrollable epilepsy. If you have deep brain stimulation leads in, this is not an option.

  • Electroconvulsive therapy, also known as electroshock therapy: A procedure done under general anesthesia in which small electric currents are passed through the brain to intentionally trigger a brief seizure. This seems to cause changes in brain chemistry that can quickly reverse symptoms of certain mental illness. It is highly effective and well tolerated in refractory depression.

Anxiety: Symptoms and treatment

About 5 to 40 percent of people with Parkinson's disease also have a clinical diagnosis of anxiety — feelings of worry, nervousness or unease that may be accompanied by compulsive behavior or panic attacks. Some of these symptoms can be worse or occur only when Sinemet is wearing off ("off times").

To treat anxiety in Parkinson's patients, we would use one or a combination of the following:

  • Cognitive behavioral therapy

  • Psychotherapy

  • Relaxation techniques

  • Adjust the carbidopa-levodopa (Sinemet) regiment to treat any anxiety that occurs during medication "off" times

  • Medications used for depression as described above usually work well for anxiety

  • Anxiolytics like lorazepam (Ativan) or diazepam (Valium) are rarely used due to effects on thinking and alertness

A need for caution

Doctors have to be careful which medications they prescribe. Some antipsychotic medications, for example, risk making Parkinson's motor symptoms worse — or, in combination with Parkinson's medications, can worsen any psychosis.

Watch Dr. Ridder's talk from the University of Michigan's 2016 Parkinson's & You Symposium. Dr. Ridder explains the non-motor (non-movement) cognitive and psychiatric problems seen in people with Parkinson's disease, focusing on frequency, symptoms and treatment options.


More Articles About: Health Management Parkinson's Disease anxiety Depression Neurological (Brain) Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
Understanding Dementia Risk Factors with Helen C. Kales, MD
In this episode, Matt & Lauren have the unique opportunity to talk with Dr. Helen C. Kales, a geriatric psychiatrist and health services researcher who has participated in the previous Lancet Commissions on Dementia Prevention, Intervention and Care – including the most recent one released in 2024. Dr. Kales discusses how the commission puts together all the evidence to make recommendations that can play a crucial role in dementia prevention. Dr. Kales is the Chair of the Department of Psychiatry and Behavioral Sciences and Joe P. Tupin Professor of Psychiatry at the University of California at Davis and has dedicated much of her career to improving the lives of patients living with dementia.
Health Lab
Preventing suicide during pregnancy and after birth
Many deaths by suicide during pregnancy and after birth are preventable. Along with a personal patient experience, three Michigan Medicine experts discuss the current landscape of suicide prevention in pregnant and postpartum people, including the latest research and resources for help.
Graphic of food to include in a diabetic diet
Health Lab
Healthy good tidings: 20 ways to manage your diet this season
Staying healthy during the holidays can be a tall order, but arranging your plate and your plans with these tips can help.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
The Link Between Hearing Loss and Cognitive Decline
Hearing loss is one of the most common conditions of aging, affecting nearly two-thirds of older adults over the age of 70, but it’s not just a matter of diminished hearing. Hearing loss can contribute to poor psychosocial outcomes for patients including loneliness, depression, and social isolation. New research also shows that hearing loss is linked to a higher risk of cognitive decline and dementia. In fact, the 2024 Lancet Commission on Dementia Prevention, Intervention, and Care identified hearing loss as one of 14 modifiable risk factors for dementia. According to the commission, treating hearing loss could prevent up to 7% of dementia cases globally, making it one of the most impactful areas for potential prevention. This raises the question of whether use of hearing aids in people with hearing loss can reduce or mitigate this increased dementia risk. To help us understand these connections and the latest research in this area, we are joined today by Dr. Alison Huang, an epidemiologist and Senior Research Associate from the Johns Hopkins Cochlear Center for Hearing and Public Health. Her research studies the impact of sensory loss on cognitive and mental health in older adults. Dr. Huang was an author of the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) study, a large, multicenter randomized controlled trial that tested whether treating hearing loss in older adults could help slow cognitive decline published in the Lancet. Alison Huang, PhD, MPH Link to article: Lin FR, Pike JR, Albert MS, Arnold M, Burgard S, Chisolm T, Couper D, Deal JA, Goman AM, Glynn NW, Gmelin T, Gravens-Mueller L, Hayden KM, Huang AR, Knopman D, Mitchell CM, Mosley T, Pankow JS, Reed NS, Sanchez V, Schrack JA, Windham BG, Coresh J; ACHIEVE Collaborative Research Group. Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial. Lancet. 2023 Sep 2;402(10404):786-797. doi: 10.1016/S0140-6736(23)01406-X. Epub 2023 Jul 18. PMID: 37478886; PMCID: PMC10529382.
couple holding old photo of themselves in black and white in same position
Health Lab
Treating a brain aneurysm with the market’s tiniest flow diverter
Treating a brain aneurysm with the market's tiniest flow diverter
young adult male hugging blonde haired dog
Health Lab
Cutting edge brain neurostimulator device significantly reduces 21-year-old’s seizures
A 21-year-old patient benefits from a novel application of responsive neurostimulation, also known asRNS, surgery to reduce seizures from drug-resistant epilepsy.